We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
1076
Pliant Therapeutics
PLRX
$65M
$95.5K ﹤0.01%
+82,300
New +$116K
OMER icon
1077
Omeros
OMER
$923M
$95.1K ﹤0.01%
31,715
– –
UONEK icon
1078
Urban One Class D
UONEK
$24.6M
$95K ﹤0.01%
15,060
-365
-2% -$2.18K
LSF icon
1079
Laird Superfood
LSF
$45M
$94.5K ﹤0.01%
15,000
– –
OABI icon
1080
OmniAb
OABI
$302M
$93.8K ﹤0.01%
+53,900
New +$90.2K
FIRY
1081
Firy Inc
FIRY
$149M
$93.4K ﹤0.01%
+13,700
New +$76.1K
FDMT icon
1082
4D Molecular Therapeutics
FDMT
$538M
$92.8K ﹤0.01%
25,000
+12,516
+100% +$44K
CNTY icon
1083
Century Casinos
CNTY
$33.8M
$92.3K ﹤0.01%
43,649
-963
-2% -$1.72K
INUV icon
1084
Inuvo
INUV
$17.8M
$92K ﹤0.01%
20,000
– –
NMRA icon
1085
Neumora Therapeutics
NMRA
$296M
$91.7K ﹤0.01%
+125,000
New +$94.7K
NAUT icon
1086
Nautilus Biotechnolgy
NAUT
$119M
$90.6K ﹤0.01%
125,000
+75,000
+150% +$56.3K
ELDN icon
1087
Eledon Pharmaceuticals
ELDN
$267M
$90.5K ﹤0.01%
33,400
– –
VERI icon
1088
Veritone
VERI
$111M
$89.7K ﹤0.01%
71,200
-1,200
-2% -$2.18K
ZNTL icon
1089
Zentalis Pharmaceuticals
ZNTL
$348M
$89.7K ﹤0.01%
77,300
-75,000
-49% -$98.9K
CVU icon
1090
CPI Aerostructures
CVU
$66.7M
$89.3K ﹤0.01%
25,500
– –
SPRU icon
1091
Spruce Power Holding Corp
SPRU
$43.4M
$88.9K ﹤0.01%
44,025
– –
RBOT
1092
DELISTED
Vicarious Surgical
RBOT
$88.5K ﹤0.01%
11,800
– –
CMTL icon
1093
Comtech Telecommunications
CMTL
$50.6M
$85.8K ﹤0.01%
35,000
-10,000
-22% -$18K
CDLX icon
1094
Cardlytics
CDLX
$24.1M
$85.5K ﹤0.01%
5,200
– –
ARMP icon
1095
Armata Pharmaceuticals
ARMP
$171M
$84.9K ﹤0.01%
44,682
– –
LOAN
1096
Manhattan Bridge Capital
LOAN
$47.1M
$83.2K ﹤0.01%
15,216
– –
GSIT icon
1097
GSI Technology
GSIT
$249M
$82.3K ﹤0.01%
24,500
-17,217
-41% -$52.5K
RDNW
1098
RideNow Group
RDNW
$259M
$80.5K ﹤0.01%
34,840
– –
IMUX icon
1099
Immunic
IMUX
$189M
$80.2K ﹤0.01%
11,500
– –
AWX icon
1100
Avalon Holdings
AWX
$10M
$78.5K ﹤0.01%
31,528
-2,972
-9% -$7.46K
42 43
44
45 46

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.